• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多不饱和脂肪酸(PUFAs)和类二十烷酸在干眼症症状和体征中的作用。

Role of Polyunsaturated Fatty Acids (PUFAs) and Eicosanoids on Dry Eye Symptoms and Signs.

机构信息

Surgical Services, Department of Ophthalmology, Miami Veterans Affairs Medical Center, 1201 NW 17th Street, Miami, FL 33125, USA.

Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, 900 NW 17th Street, Miami, FL 33136, USA.

出版信息

Biomolecules. 2024 Mar 20;14(3):376. doi: 10.3390/biom14030376.

DOI:10.3390/biom14030376
PMID:38540794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10968634/
Abstract

Polyunsaturated fatty acids (PUFAs) generate pro- and anti-inflammatory eicosanoids via three different metabolic pathways. This study profiled tear PUFAs and their metabolites and examined the relationships with dry eye (DE) and meibomian gland dysfunction (MGD) symptoms and signs. A total of 40 individuals with normal eyelids and corneal anatomies were prospectively recruited. The symptoms and signs of DE and MGD were assessed, and tear samples (from the right eye) were analyzed by mass spectrometry. Mann-Whitney U tests assessed differences between medians; Spearman tests assessed correlations between continuous variables; and linear regression models assessed the impact of potential confounders. The median age was 63 years; 95% were male; 30% were White; and 85% were non-Hispanic. The symptoms of DE/MGD were not correlated with tear PUFAs and eicosanoids. DE signs (i.e., tear break-up time (TBUT) and Schirmer's) negatively correlated with anti-inflammatory eicosanoids (11,12-dihydroxyeicosatrienoic acid (11,12 DHET) and 14,15-dihydroxyicosatrienoic acid (14,15, DHET)). Corneal staining positively correlated with the anti-inflammatory PUFA, docosahexaenoic acid (DHA). MGD signs significantly associated with the pro-inflammatory eicosanoid 15-hydroxyeicosatetranoic acid (15-HETE) and DHA. Several relationships remained significant when potential confounders were considered. DE/MGD signs relate more to tear PUFAs and eicosanoids than symptoms. Understanding the impact of PUFA-related metabolic pathways in DE/MGD may provide targets for new therapeutic interventions.

摘要

多不饱和脂肪酸(PUFAs)通过三种不同的代谢途径生成促炎和抗炎类二十烷酸。本研究分析了泪液 PUFAs 及其代谢产物,并探讨了其与干眼(DED)和睑板腺功能障碍(MGD)症状和体征的关系。共前瞻性招募了 40 名具有正常眼睑和角膜解剖结构的个体。评估了 DED 和 MGD 的症状和体征,并通过质谱法分析了泪液样本(右眼)。使用 Mann-Whitney U 检验评估中位数之间的差异;Spearman 检验评估连续变量之间的相关性;线性回归模型评估潜在混杂因素的影响。中位年龄为 63 岁;95%为男性;30%为白人;85%为非西班牙裔。DED/MGD 症状与泪液 PUFAs 和类二十烷酸无相关性。DED 体征(即泪膜破裂时间(TBUT)和 Schirmer 试验)与抗炎类二十烷酸(11,12-二羟基二十碳三烯酸(11,12-DHET)和 14,15-二羟基二十碳三烯酸(14,15-DHET))呈负相关。角膜染色与抗炎性 PUFAs,二十二碳六烯酸(DHA)呈正相关。MGD 体征与促炎类二十烷酸 15-羟二十碳四烯酸(15-HETE)和 DHA 显著相关。当考虑潜在混杂因素时,有几个关系仍然具有统计学意义。DED/MGD 体征与泪液 PUFAs 和类二十烷酸的相关性大于症状。了解 PUFA 相关代谢途径在 DED/MGD 中的作用可能为新的治疗干预提供靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d8/10968634/c95e4f286c59/biomolecules-14-00376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d8/10968634/c95e4f286c59/biomolecules-14-00376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6d8/10968634/c95e4f286c59/biomolecules-14-00376-g001.jpg

相似文献

1
Role of Polyunsaturated Fatty Acids (PUFAs) and Eicosanoids on Dry Eye Symptoms and Signs.多不饱和脂肪酸(PUFAs)和类二十烷酸在干眼症症状和体征中的作用。
Biomolecules. 2024 Mar 20;14(3):376. doi: 10.3390/biom14030376.
2
Systemic secukinumab treatment in patients with ankylosing spondylitis: the relationship between systemic and tear proinflammatory cytokines and ocular surface findings-a pilot study.强直性脊柱炎患者的司库奇尤单抗全身治疗:全身与泪液促炎细胞因子之间的关系及眼表表现——一项试点研究
Clin Rheumatol. 2025 May 20. doi: 10.1007/s10067-025-07492-y.
3
Is Meibomian Gland Dysfunction One Disease? Heterogeneity Among Phenotypes.睑板腺功能障碍是一种疾病吗?表型的异质性。
Cornea. 2024 Nov 1;43(11):1410-1417. doi: 10.1097/ICO.0000000000003542. Epub 2024 Apr 2.
4
Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.补充多不饱和脂肪酸治疗耐药性癫痫。
Cochrane Database Syst Rev. 2016 Aug 17;2016(8):CD011014. doi: 10.1002/14651858.CD011014.pub2.
5
A Multicenter, Randomized, Clinical Trial Assessing the Effect of rTG-Omega 3 Supplementation on Meibomian Gland Dysfunction Patients after Cataract Surgery rTG-Omega 3 for Meibomian Gland Dysfunction.一项多中心、随机临床试验,评估补充rTG-ω-3对白内障手术后睑板腺功能障碍患者的影响:rTG-ω-3用于睑板腺功能障碍
J Ocul Pharmacol Ther. 2025 Mar;41(2):65-74. doi: 10.1089/jop.2024.0160. Epub 2025 Feb 5.
6
Efficacy of meibomian gland expression combined with Home-Based therapy in the management of dry eye Disease: A systematic review and Meta-Analysis.睑板腺按摩联合家庭治疗干眼病的疗效:系统评价和 Meta 分析。
Cont Lens Anterior Eye. 2024 Apr;47(2):102107. doi: 10.1016/j.clae.2023.102107. Epub 2023 Dec 22.
7
Topical corticosteroids for dry eye.局部皮质类固醇治疗干眼。
Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD015070. doi: 10.1002/14651858.CD015070.pub2.
8
Autologous serum eye drops for dry eye.用于干眼症的自体血清眼药水。
Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD009327. doi: 10.1002/14651858.CD009327.pub3.
9
Autologous serum eye drops for dry eye.用于干眼症的自体血清眼药水。
Cochrane Database Syst Rev. 2013 Aug 27;8(8):CD009327. doi: 10.1002/14651858.CD009327.pub2.
10
Real-world practice patterns for dry eye diagnosis: a multicenter observational study in Taiwan.干眼症诊断的真实世界实践模式:台湾的一项多中心观察性研究。
Jpn J Ophthalmol. 2025 May;69(3):343-350. doi: 10.1007/s10384-025-01175-6. Epub 2025 Mar 8.

本文引用的文献

1
Skewing cPLAα activity toward oxoeicosanoid production promotes neutrophil N2 polarization, wound healing, and the response to sepsis.使 cPLAα 活性偏向氧化二十碳烯酸产物会促进中性粒细胞 N2 极化、伤口愈合和对脓毒症的反应。
Sci Signal. 2023 Jul 11;16(793):eadd6527. doi: 10.1126/scisignal.add6527.
2
Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy.血浆中的生物活性脂质介质是子痫前期的预测因子,与阿司匹林治疗无关。
J Lipid Res. 2023 Jun;64(6):100377. doi: 10.1016/j.jlr.2023.100377. Epub 2023 Apr 27.
3
Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
海洋 ω-3 脂肪酸补充剂与安慰剂在降低健康美国成年人干眼症发病率方面的疗效:一项随机临床试验。
JAMA Ophthalmol. 2022 Jul 1;140(7):707-714. doi: 10.1001/jamaophthalmol.2022.1818.
4
Ceramide Kinase Inhibition Drives Ferroptosis and Sensitivity to Cisplatin in Mutant KRAS Lung Cancer by Dysregulating VDAC-Mediated Mitochondria Function.鞘氨醇激酶抑制通过调节 VDAC 介导的线粒体功能驱动突变 KRAS 肺癌中的铁死亡和对顺铂的敏感性。
Mol Cancer Res. 2022 Sep 2;20(9):1429-1442. doi: 10.1158/1541-7786.MCR-22-0085.
5
Ceramide kinase regulates acute wound healing by suppressing 5-oxo-ETE biosynthesis and signaling via its receptor OXER1.神经酰胺激酶通过其受体 OXER1 抑制 5-氧二十碳四烯酸(5-oxo-ETE)生物合成和信号传导来调节急性伤口愈合。
J Lipid Res. 2022 Apr;63(4):100187. doi: 10.1016/j.jlr.2022.100187. Epub 2022 Feb 24.
6
Effect of a Novel Omega-3 and Omega-6 Fatty Acid Supplement on Dry Eye Disease: A 3-month Randomized Controlled Trial.一种新型ω-3和ω-6脂肪酸补充剂对干眼病的影响:一项为期3个月的随机对照试验。
Optom Vis Sci. 2022 Jan 1;99(1):67-75. doi: 10.1097/OPX.0000000000001826.
7
Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.解析 12-和 20-HETE 在心脏病理生理学中的作用:G 蛋白偶联受体、药理学抑制剂和转基因方法。
J Cardiovasc Pharmacol. 2021 Jun 1;77(6):707-717. doi: 10.1097/FJC.0000000000001013.
8
Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.花生四烯酸的代谢途径:机制与潜在治疗靶点。
Signal Transduct Target Ther. 2021 Feb 26;6(1):94. doi: 10.1038/s41392-020-00443-w.
9
Inflammation in Dry Eye Syndrome: Identification and Targeting of Oxylipin-Mediated Mechanisms.干眼症中的炎症:氧化脂质介导机制的识别与靶向治疗
Biomedicines. 2020 Sep 11;8(9):344. doi: 10.3390/biomedicines8090344.
10
Changes of tear lipid mediators after eyelid warming or thermopulsation treatment for meibomian gland dysfunction.睑板腺功能障碍患者经眼睑热敷或热脉动治疗后泪液脂质介质的变化
Prostaglandins Other Lipid Mediat. 2020 Dec;151:106474. doi: 10.1016/j.prostaglandins.2020.106474. Epub 2020 Aug 9.